Industry Developments

After turning a sharp 2005 loss into a solid CLN7.05bn (US$13.3mn) profit in 2006, leading Chilean and regional pharmacy chain Farmacia Ahumada (Fasa) is shifting gears from cost-cutting... 2007-07-12

US pharmaceutical giant Pfizer has launched its Exubera inhaled insulin product in Mexico, following earlier launches in the US, Brazil and European Union (EU). Diabetes is one of... 2007-07-11

US drugmaker

The Department of Health of Puerto Rico has unveiled a plan to deal with future health emergencies and ensure the availability of free essential medicines, such as antibiotics, vaccines,... 2007-07-03

US conglomerate

The US and Mexico are in discussions about providing cross-border healthcare for Mexican immigrants. The outline of plan envisages migrants having access to health services regardless... 2007-06-19

The US FDA has approved Letairis (ambrisentan0, a new drug from US-based drugmaker

Johnson & Johnson (J&J) is hopeful that the purchase of fellow US healthcare giant Pfizer's OTC division in 2006, for US$16.6bn will help drive sales in the coming years.... 2007-06-11

The CEO of US-based biotech major Genentech has defended his firm's pricing policies in a recent interview with the Wall Street Journal. Pointing out that the company invested US$1.8bn... 2007-06-08

Dorsay Monange (DM) Farmacêutica, one of Brazil's leading over-the-counter (OTC) producers, is reportedly being sold to recently formed consumer products holding Hypermarcas. The... 2007-06-08